Concepedia

Kathleen Butler

KB

38

Publications

4.1K

Citations

27

H-Index

1996

Active since

Affiliations

AstraZeneca (United States)(Current)

AstraZeneca (United Kingdom)

University of Sheffield

AstraZeneca (Singapore)

University of Massachusetts Chan Medical School

Kathleen Butler is an author at AstraZeneca (United States) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1996–2024

38

Publications

38

Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease

Paul A. Gurbel, Kevin P. Bliden, Kathleen Butler et al. · Circulation · 2009 · 1.1K citations

Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies

Paul A. Gurbel, Kevin P. Bliden, Kathleen Butler et al. · Circulation · 2010 · 441 citations

Absorption, Distribution, Metabolism, and Excretion of Ticagrelor in Healthy Subjects

Renli Teng, Stuart Oliver, Martin A. Hayes et al. · Drug Metabolism and Disposition · 2010 · 260 citations

Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial

David Rosmarin, Amit G. Pandya, Mark Lebwohl et al. · The Lancet · 2020 · 241 citations

, , +3

Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo

David Rosmarin, Thierry Passeron, Amit G. Pandya et al. · New England Journal of Medicine · 2022 · 232 citations

Rows per page

1–5 of 38